Suivre
Corinne Faivre-Finn
Corinne Faivre-Finn
Professor of Thoracic Radiation Oncology, Institute of Cancer Sciences (University of Manchester)
Adresse e-mail validée de christie.nhs.uk
Titre
Citée par
Citée par
Année
Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC
SJ Antonia, A Villegas, D Daniel, D Vicente, S Murakami, R Hui, T Kurata, ...
New England Journal of Medicine 379 (24), 2342-2350, 2018
25712018
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
D Planchard, ST Popat, K Kerr, S Novello, EF Smit, C Faivre-Finn, TS Mok, ...
Annals of Oncology 29, iv192-iv237, 2018
2345*2018
Prophylactic cranial irradiation in extensive small-cell lung cancer
B Slotman, C Faivre-Finn, G Kramer, E Rankin, M Snee, M Hatton, ...
New England Journal of Medicine 357 (7), 664-672, 2007
13112007
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
A Brunelli, A Charloux, CT Bolliger, G Rocco, JP Sculier, G Varela, ...
European Respiratory Journal 34 (1), 17-41, 2009
1043*2009
Imaging biomarker roadmap for cancer studies
JPB O'connor, EO Aboagye, JE Adams, HJWL Aerts, SF Barrington, ...
Nature reviews Clinical oncology 14 (3), 169-186, 2017
10142017
Small-cell lung cancer
CM Rudin, E Brambilla, C Faivre-Finn, J Sage
Nature Reviews Disease Primers 7 (1), 3, 2021
7292021
Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection …
P Mulvenna, M Nankivell, R Barton, C Faivre-Finn, P Wilson, E McColl, ...
The Lancet 388 (10055), 2004-2014, 2016
6742016
Guidelines on the radical management of patients with lung cancer
E Lim, D Baldwin, M Beckles, J Duffy, J Entwisle, C Faivre-Finn, K Kerr, ...
Thorax 65 (Suppl 3), iii1-iii27, 2010
6652010
Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial
BJ Slotman, H van Tinteren, JO Praag, JL Knegjens, SY El Sharouni, ...
The Lancet 385 (9962), 36-42, 2015
5832015
Five-year survival outcomes from the PACIFIC trial: durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer
DR Spigel, C Faivre-Finn, JE Gray, D Vicente, D Planchard, L Paz-Ares, ...
Journal of Clinical Oncology 40 (12), 1301, 2022
5612022
2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up
J Vansteenkiste, L Crino, C Dooms, JY Douillard, C Faivre-Finn, E Lim, ...
Annals of Oncology 25 (8), 1462-1474, 2014
5332014
Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial
C Faivre-Finn, M Snee, L Ashcroft, W Appel, F Barlesi, A Bhatnagar, ...
The Lancet Oncology 18 (8), 1116-1125, 2017
4892017
European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer
D De Ruysscher, C Faivre-Finn, U Nestle, CW Hurkmans, C Le Péchoux, ...
Journal of clinical oncology 28 (36), 5301-5310, 2010
487*2010
Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
N Girard, E Ruffini, A Marx, C Faivre-Finn, S Peters
Annals of Oncology 26, v40-v55, 2015
4352015
Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and …
C Le Péchoux, A Dunant, S Senan, A Wolfson, E Quoix, C Faivre-Finn, ...
The lancet oncology 10 (5), 467-474, 2009
4292009
2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer
WEE Eberhardt, D De Ruysscher, W Weder, C Le Pechoux, P De Leyn, ...
Annals of Oncology 26 (8), 1573-1588, 2015
4022015
Three-year overall survival with durvalumab after chemoradiotherapy in stage III NSCLC—update from PACIFIC
JE Gray, A Villegas, D Daniel, D Vicente, S Murakami, R Hui, T Kurata, ...
Journal of Thoracic Oncology 15 (2), 288-293, 2020
4012020
Four-year survival with durvalumab after chemoradiotherapy in stage III NSCLC—an update from the PACIFIC trial
C Faivre-Finn, D Vicente, T Kurata, D Planchard, L Paz-Ares, ...
Journal of Thoracic Oncology 16 (5), 860-867, 2021
3872021
Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer
E Touboul, L Buffat, Y Belkacémi, JP Lefranc, S Uzan, P Lhuillier, C Faivre, ...
Int J Radiat Oncol Biol Phys 43 (1), 25-38, 1999
3661999
Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer
KM Kerr, L Bubendorf, MJ Edelman, A Marchetti, T Mok, S Novello, ...
Annals of Oncology 25 (9), 1681-1690, 2014
3582014
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20